OraSure Technologies Inc. (OSUR)
NASDAQ: OSURHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
OSUR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $257.25M
- EPS (TTM)
- -$0.69
- Dividend yield
- None
- Ex-dividend date
- Jan 8, 1998
- 52-week range
- 2.08 – 4.58
- Day range
- 3.63 – 3.86
- Volume / Avg
- 435.06K / 480.98K
- Beta
- —
- Shares outstanding
- 68.97M
- Next earnings
- Nov 4, 2026
52-week range
OSUR stock today
OraSure Technologies (OSUR) closed at $3.73 on Oct 7, down 1.06% (-$0.04), versus the S&P 500's 0.22% decline. Shares are 18.6% below their 52-week high of $4.58, set on Jun 17, 2026 and 79.3% above the 52-week low of $2.08, in the middle of the past year's range. OSUR is up 54.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 18.0%.
OraSure Technologies has posted a net loss over the last twelve months (EPS of -$0.69), so its P/E ratio is not meaningful. OraSure Technologies's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About OraSure Technologies
Company profileOraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Carrie Eglinton Manner
- Headquarters
- Bethlehem, PA
- Employees
- 500
- Website
- orasure.com
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$4.00+7.24%
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.22
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.60
- Ex-dividend date
- Jan 8, 1998
OraSure Technologies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANIKAnika Therapeutics Inc. | 19.53 | +2.14% | $261.37M | vs OSUR |
| INFUInfuSystems Holdings Inc. | 13.33 | +0.45% | $265.50M | vs OSUR |
| TMCITreace Medical Concepts Inc. | 3.89 | -2.75% | $252.98M | vs OSUR |
| MOBIMobia Medical Inc. | 8.51 | -3.30% | $283.31M | vs OSUR |
| UTMDUtah Medical Products Inc. | 73.45 | -0.51% | $233.12M | vs OSUR |
| PROFProfound Medical Corp. | 5.68 | -6.58% | $207.55M | vs OSUR |
| KTWOK2 Capital Acquisition Corporation Class A | 10.07 | -0.20% | $201.81M | vs OSUR |
| PDEXPro-Dex Inc. | 62.80 | -3.27% | $201.17M | vs OSUR |
Indexes, lists and sector
Appears in lists
OraSure Technologies stock FAQ
What is OraSure Technologies's stock price today?
OSUR last traded at $3.73 as of Oct 7, 4:00 PM EDT, down 1.06% on the day. Prices are delayed at least 15 minutes.
Does OraSure Technologies pay a dividend?
Yes. OraSure Technologies pays $0.00 per share annually. The most recent dividend of $1.60 had an ex-dividend date of Jan 8, 1998.
When is OraSure Technologies's next earnings date?
OraSure Technologies is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.22.
Who is OraSure Technologies's CEO?
Ms. Carrie Eglinton Manner is the chief executive officer of OraSure Technologies Inc., which has about 500 employees.
Has OSUR ever split its stock?
Yes. The most recent OSUR stock split was a 3-for-1 split on Apr 8, 1987.
What is the OSUR 52-week high?
The 52-week high for OSUR is $4.58 and the 52-week low is $2.08. The stock is currently 18.6% below its high.